Recurrent Childhood Soft Tissue Sarcoma Completed Phase 1 Trials for Cixutumumab (DB12250)

IndicationStatusPhase
DBCOND0029296 (Recurrent Childhood Soft Tissue Sarcoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00720174Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaTreatment